Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (151-160 of 230) with videos related to

Pageof 23
Sort By:
Diabetes Care|July 27, 2005
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)Lena M Thorn, Carol Forsblom, Johan Fagerudd, et al.
Lipids in Health and Disease|December 15, 2018
USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophagesMaija Ruuth, Jarkko Soronen, Essi Kaiharju, et al.
Diabetologia|June 10, 2015
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes studyKwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
Human Molecular Genetics|December 17, 2005
Cross-species analyses implicate Lipin 1 involvement in human glucose metabolismElina Suviolahti, Karen Reue, Rita M Cantor, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 26, 2009
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolismJulia Perttilä, Krista Merikanto, Jussi Naukkarinen, et al.
Journal of Clinical Lipidology|January 10, 2020
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjectsMarja-Riitta Taskinen, Elias Björnson, Linda Andersson, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemiaAngelo B Cefalù, Davide Noto, Maria Luisa Arpi, et al.
Diabetes, Obesity & Metabolism|April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyJacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
JCI Insight|November 10, 2020
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
Human Genetics|October 10, 2009
A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemiaAdriana Huertas-Vazquez, Christopher L Plaisier, Ruishuang Geng, et al.
Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:
Pageof 23
Diabetes Care|July 27, 2005
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)Lena M Thorn, Carol Forsblom, Johan Fagerudd, et al.
Lipids in Health and Disease|December 15, 2018
USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophagesMaija Ruuth, Jarkko Soronen, Essi Kaiharju, et al.
Diabetologia|June 10, 2015
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes studyKwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
Human Molecular Genetics|December 17, 2005
Cross-species analyses implicate Lipin 1 involvement in human glucose metabolismElina Suviolahti, Karen Reue, Rita M Cantor, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 26, 2009
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolismJulia Perttilä, Krista Merikanto, Jussi Naukkarinen, et al.
Journal of Clinical Lipidology|January 10, 2020
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjectsMarja-Riitta Taskinen, Elias Björnson, Linda Andersson, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemiaAngelo B Cefalù, Davide Noto, Maria Luisa Arpi, et al.
Diabetes, Obesity & Metabolism|April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyJacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
JCI Insight|November 10, 2020
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
Human Genetics|October 10, 2009
A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemiaAdriana Huertas-Vazquez, Christopher L Plaisier, Ruishuang Geng, et al.
Pageof 23